Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Resection Combined With Chemoradiotherapy in Early-stage Rectal Cancer
NCT06949098Phase 2Recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- May 2025
- Primary completion
- Mar 2032
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in rectal cancer, sponsored by The Fourth Hospital of Hebei Medical University. Started May 2025; status: recruiting.
02
Drugs
capecitabine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06949098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06949098.